2-(3-methoxyphenyl)-N-phenethylacetamide | 30980-70-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(3-methoxyphenyl)-N-phenethylacetamide
• 英文别名: (N-β-Phenylaethyl)-3-methoxyphenylacetamid；3-Methoxy-phenylessigsaeure-<2-phenyl-ethylamid>；2-(3-methoxyphenyl)-N-(2-phenylethyl)acetamide
• CAS: 30980-70-2
• 化学式: C₁₇H₁₉NO₂
• 分子量: 269.343
• InChiKey: ASKLAJFUVXSEJF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  20
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  38.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-(3-methoxyphenyl)-N-phenethylacetamide 在 lithium aluminium tetrahydride 作用下， 以 甲基叔丁基醚 为溶剂， 以19%的产率得到2-(3-methoxyphenyl)ethyl-N-phenethylamine
  参考文献：
  名称：

  A New Class of Selective and Potent 7-Dehydrocholesterol Reductase Inhibitors

  摘要：

  We prepared a number of N-phenethyltetrahydroisoquinolines structurally related to protoberberines. They were tested for activity against bacteria, fungi, and human leukemia HL-60 cells and also for inhibition of biosynthesis: ergosterol in yeasts and cholesterol in human cells. In the latter assay panel, several of the compounds were distinguished by a strong and selective inhibition of 7-dehydrocholesterol reductase (7-DHCR, EC 1.3.1.21), an enzyme responsible for the conversion of 7-dehydrocholesterol to cholesterol in the last step of cholesterol biosynthesis. In a whole-cell assay, the most active compound 5f showed a much stronger inhibition of overall cholesterol biosynthesis (IC50 2.3 nM) than BM 15.766 (IC50 500 nM), presently the most selective known inhibitor of 7-DHCR Since a defect of 7-dehydrocholesterol reductase is associated with Smith-Lemli-Opitz syndrome (SLOS), the potent and selective inhibitors reported here will enable more detailed investigation of the pathogenesis of SLOS.

  DOI：

  10.1021/jm3006096
• 作为产物：
  描述：

  苄胺 、 3-甲氧基苯基乙酰氯 在 三乙胺 作用下， 以 氯仿 为溶剂， 以87%的产率得到2-(3-methoxyphenyl)-N-phenethylacetamide
  参考文献：
  名称：

  一些取代的1-苄基-3,4-二氢异喹啉的合成和光氧合。烯胺光氧合的机理

  摘要：

  描述了通过Bischler-Napieralski环化合成一系列取代的1-苄基-3,4-二氢异喹啉。竞争性的亚甲基蓝敏化光氧合实验可确定1-苄基-3,4-二氢异喹啉的光氧合相对速率，已证明取代基会影响互变异构烯胺的平衡浓度和总光氧合速率。在校正了烯胺浓度的差异之后，相对速率数据提供了反应机理的诊断探针，该机理涉及限速步骤中电荷的转移。

  DOI：

  10.1002/hlca.19820650314

文献信息

• MARTIN, N. H.;JEFFORD, C. W., HELV. CHIM. ACTA, 1982, 65, N 3, 762-774
  作者：MARTIN, N. H.、JEFFORD, C. W.

  DOI：——

  日期：——
• Synthesis and Photo-oxygenation of Some Substituted 1-Benzyl-3,4-dihydroisoquinolines. Mechanism of Enamine Photo-oxygenation
  作者：Ned H. Martin、Charles W. Jefford

  DOI：10.1002/hlca.19820650314

  日期：1982.5.5

  Bischler-Napieralski cyclization is described. Competitive methylene blue sensitized photo-oxygenation experiments allowed the determination of relative rates of photo-oxygenation of 1-benzyl-3,4-dihydroisoquinolines, Substituents were shown to affect both the equilibrium concentration of the tautomeric enamine and the overall photo-oxygenation rate. After correcting for differences in enamine concentration, the relative

  描述了通过Bischler-Napieralski环化合成一系列取代的1-苄基-3,4-二氢异喹啉。竞争性的亚甲基蓝敏化光氧合实验可确定1-苄基-3,4-二氢异喹啉的光氧合相对速率，已证明取代基会影响互变异构烯胺的平衡浓度和总光氧合速率。在校正了烯胺浓度的差异之后，相对速率数据提供了反应机理的诊断探针，该机理涉及限速步骤中电荷的转移。
• A New Class of Selective and Potent 7-Dehydrocholesterol Reductase Inhibitors
  作者：Aline Horling、Christoph Müller、Richard Barthel、Franz Bracher、Peter Imming

  DOI：10.1021/jm3006096

  日期：2012.9.13

  We prepared a number of N-phenethyltetrahydroisoquinolines structurally related to protoberberines. They were tested for activity against bacteria, fungi, and human leukemia HL-60 cells and also for inhibition of biosynthesis: ergosterol in yeasts and cholesterol in human cells. In the latter assay panel, several of the compounds were distinguished by a strong and selective inhibition of 7-dehydrocholesterol reductase (7-DHCR, EC 1.3.1.21), an enzyme responsible for the conversion of 7-dehydrocholesterol to cholesterol in the last step of cholesterol biosynthesis. In a whole-cell assay, the most active compound 5f showed a much stronger inhibition of overall cholesterol biosynthesis (IC50 2.3 nM) than BM 15.766 (IC50 500 nM), presently the most selective known inhibitor of 7-DHCR Since a defect of 7-dehydrocholesterol reductase is associated with Smith-Lemli-Opitz syndrome (SLOS), the potent and selective inhibitors reported here will enable more detailed investigation of the pathogenesis of SLOS.